MedPath

MOLOGIC LTD.

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

COPD Exacerbation Alert System With urinE anaLysis Using the HEADSTART Device

Terminated
Conditions
COPD Exacerbation
First Posted Date
2020-03-05
Last Posted Date
2022-07-28
Lead Sponsor
Mologic Ltd
Target Recruit Count
86
Registration Number
NCT04296318
Locations
🇬🇧

Institute for Lung Health, Glenfield Hospital, Leicester, Leicestershire, United Kingdom

Study of Urinary Predictors of Exacerbations by Biomarkers in Cystic Fibrosis

Completed
Conditions
Cystic Fibrosis
First Posted Date
2020-03-05
Last Posted Date
2020-03-11
Lead Sponsor
Mologic Ltd
Target Recruit Count
29
Registration Number
NCT04297709
Locations
🇬🇧

Birmingham Heartlands Hospital, Birmingham, United Kingdom

The Performance of the Mologic Biomarker Panel in Infection

Conditions
Infection
Sepsis
First Posted Date
2017-07-14
Last Posted Date
2018-03-29
Lead Sponsor
Mologic Ltd
Target Recruit Count
600
Registration Number
NCT03217552
Locations
🇬🇧

University College London Hospital, London, United Kingdom

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.